EN | UA
EN | UA

Help Support

Back

Gene variations can significantly influence Sufentanil labor pain relief

Labor analgesia Labor analgesia
Labor analgesia Labor analgesia

What's new?

Understanding how genetic factors impact Sufentanil's effectiveness in labor pain relief can pave the way for more personalized pain management strategies.

In a recent cohort study based on propensity score matching, Yao Chen et al. explored the impact of opioid receptor µ 1 (OPRM1) and Catechol-O-methyltransferase (COMT) gene polymorphisms on the effectiveness of Sufentanil in providing labor analgesia. According to the findings of the study, Sufentanil might offer more effective epidural labor pain relief in individuals with OPRM1 AA and COMT GA/AA gene variants as opposed to those with OPRM1 AG/GG and COMT GG gene variants.

The study focused on 136 pairs of parturients using Sufentanil in combination with Lidocaine and Ropivacaine for epidural analgesia. The visual analogue scale (VAS) score and Sufentanil consumption were considered the key metrics for analysis. The results of the study revealed that individuals with OPRM1 AG/GG genotypes experienced a lower VAS score difference between the fifth minute and the initial assessment (1.55 versus 1.87) and consumed more Sufentanil (19.65 μg versus 17.11 μg) compared to those with the AA genotype.

Conversely, individuals with COMT GA/AA genotypes exhibited a greater VAS score difference than those with GG genotypes. Hence, gene variations can significantly affect the relief provided by Sufentanil during labor.

Source:

Future Medicine

Article:

Effect of OPRM1/COMT gene polymorphisms on Sufentanil labor analgesia: a cohort study based on propensity score matching

Authors:

Yao Chen et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: